Introduction & Objective: Both maternal adiposity and dysglycemia induce low-grade inflammation that impacts the fetal intrauterine milieu. We examined the association between maternal proinflammatory markers with gestational glycemia, and pregestational BMI.

Methods: From the Early Tracking of Childhood Health Determinants (ETCHED) longitudinal observational study, data on 66 pregnant Hispanic (73%) and American Indian women were available (May 2022-Sep 2023); 33% had diabetes. We analyzed baseline glycemic measures (fasting glucose, insulin, C-peptide, HbA1c), proinflammatory biomarkers (IL-6, hsCRP), and maternal leptin.

Results: Mean age was 29.9 years (SD ±6.3), mean pregestational BMI was 33.1 kg/m2 (SD±9.4). Table 1 shows significant positive Spearman correlations between maternal serum IL-6 and hsCRP with pregestational BMI, insulin, HbA1c, C-peptide, and leptin. There was no significant correlation between pregestational BMI and offspring birth weight. In a subset (n=40) of matched samples maternal IL-6 was correlated with cord-blood leptin (r=0.34, p=0.03) and TNF-α (r=0.31, p=0.04).

Conclusion: Gestational maternal proinflammatory cytokines were elevated in women with excess adiposity and hyperglycemia. Maternal IL-6 associated with fetal adipocytokines, however, additional data are needed to explore this relationship and its impact on fetal growth and development.

graphic
View largeDownload slide
Disclosure

L. Vazquez: None. E. Vazquez Arreola: None. H.C. Looker: None. R.L. Hanson: None. D. Wasak: None. R. Caballero: None. M. Sinha: None.

© 2024 by the American Diabetes Association
2024
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.